Fetal Monitoring Market to Grow with a CAGR of 7.01% through 2031

Rising Birth Rates and Preterm Births and Rising Maternal Age and Associated Complications are expected to drive the Global Fetal Monitoring Market growth in the forecast period, 2027-2031.

According to TechSci Research's report, “Fetal Monitoring Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F,” the global fetal monitoring market is projected to grow from USD 6.16 billion in 2025 to USD 9.25 billion by 2031, at a 7.01% CAGR.

Public health campaigns, widespread access to digital health information, and increased awareness among expecting parents have led to earlier and more consistent prenatal check-ups. The growing emphasis on fetal well-being is prompting healthcare providers to expand and upgrade their diagnostic capabilities. This trend is translating into broader adoption of fetal monitoring systems across global markets, including previously underpenetrated regions. The integration of innovations such as wireless fetal monitors, portable diagnostics, telehealth interoperability, and AI-powered analytics is redefining clinicians' approach to prenatal and intrapartum monitoring. These next-generation devices improve clinical efficiency and user accessibility, particularly for remote or underserved populations. The shift toward home-based fetal monitoring is emerging as a viable segment, offering opportunities for device manufacturers to expand beyond traditional clinical environments.

Numerous governments are scaling up national health initiatives to reduce maternal and neonatal mortality. These efforts include infrastructure funding, device subsidies, and healthcare capacity-building programs. Public-sector support is accelerating capital investments in fetal-monitoring infrastructure, particularly in low- and middle-income countries, thereby enabling broader market penetration for equipment manufacturers and service providers. Increasing healthcare budgets in developing countries are empowering both public and private institutions to modernize their maternity care offerings. This trend is driving demand for high-precision fetal monitoring technologies in newly built hospitals and diagnostic centers. In parallel, the growth of private healthcare chains is creating a competitive landscape in which technology adoption is a differentiator.

Global healthcare systems are gradually shifting from reactive to preventive models, with a focus on early diagnosis, risk mitigation, and value-based outcomes. Fetal monitoring systems are becoming central to this paradigm shift, supporting the early detection of fetal anomalies and maternal complications. This alignment with value-based care metrics makes such devices essential in modern obstetric practice. Countries such as India, Thailand, and Mexico are experiencing significant growth in medical tourism, driven by cost-effective, high-quality maternal care. To maintain competitive standards and attract international patients, hospitals in these countries are investing heavily in advanced fetal monitoring equipment, boosting sales volumes and setting higher benchmarks for regional healthcare delivery.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Fetal Monitoring Market”

The Global Fetal Monitoring Market is segmented by product, portability, method, application, end user, region, and company.

Based on its end user, the home care settings segment has emerged as the fastest growing segment, Advancements in portable, wireless, and telehealth-integrated fetal monitoring technologies have made it feasible to conduct high-quality maternal and fetal assessments outside traditional clinical settings. Pregnant women, especially those in high-risk categories or in remote regions, increasingly prefer monitoring solutions that allow them to stay in the comfort of their homes while maintaining continuous oversight from clinicians.

The COVID-19 pandemic catalyzed the adoption of remote healthcare tools. For expectant mothers, minimizing hospital visits became a safety priority. As a result, virtual prenatal care models incorporating home-based fetal monitoring devices gained traction and adoption, a trend that has continued post-pandemic due to the convenience and flexibility it offers. Home monitoring reduces hospital admissions and resource utilization, thereby lowering operational costs for healthcare systems. Payers and providers are increasingly incentivising remote monitoring as part of value-based care frameworks to reduce avoidable complications and hospitalisations, particularly in regions experiencing clinician shortages.

The Asia Pacific region is rapidly emerging as the fastest-growing market in the global fetal monitoring landscape, driven by a confluence of demographic, economic, and healthcare transformation factors. Countries across the region, including India, China, Japan, South Korea, and Southeast Asian nations, are witnessing significant momentum in maternal health investments, healthcare digitisation, and demand for advanced monitoring technologies.

Asia Pacific accounts for a substantial proportion of global births each year. Nations such as India and China alone report millions of births annually, creating sustained demand for fetal monitoring equipment. The sheer scale of the maternal population across the region provides manufacturers and service providers with a broad and expanding customer base. Several regional governments are prioritising maternal and child health through public health initiatives, including subsidised prenatal care and upgrades to hospital infrastructure. For example, India’s Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA) and China’s maternal safety programs are supporting widespread deployment of fetal monitoring systems in public hospitals and rural clinics.

Major companies operating in Global Fetal Monitoring Market are:

• Medtronic Plc
• Cardinal Health Inc.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• GE Healthcare Technologies Inc.
• FUJIFILM SonoSite, Inc
• Natus Medical Incorporated
• Huntleigh Healthcare Limited
• CooperCompanies Inc.
• CONTEC Medical Systems Co., Ltd

Download Free Sample Report

Customers may also request a 10% discount on this report.

“The Global Fetal Monitoring Market is undergoing a transformative shift, driven by technological advancements, rising maternal health awareness, and a growing emphasis on early detection and preventive care. While challenges such as regulatory complexities and cost constraints persist, the market’s long-term outlook remains highly positive. Strategic investments in innovation particularly in AI-enabled monitoring, remote care, and home-based solutions will be key to unlocking new growth opportunities. As healthcare systems across developed and emerging economies continue to prioritise maternal and neonatal outcomes, fetal monitoring is set to become an increasingly integral component of modern obstetric care worldwide”, said Mr Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Fetal Monitoring Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Ultrasound, Device, Fetal Monitors, Uterine Contraction Monitors, Fetal Electrodes, Fetal Doppler Device, Telemetry Device, Accessories and Consumables, Others), By Portability (Portable System and Non-Portable System), By Method (Invasive and Non-invasive), By Application (Antepartum, Intrapartum), By End User (Hospitals, Obstetrics & Gynecology clinic, Home Care Setting), By Region, & Competition, 2021-2031F”, has evaluated the future growth potential of Global Fetal Monitoring Market and provides statistics & information on market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Fetal Monitoring Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]